CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

Northwest Biotherapeutics Announces Keynote Presentation on Harnessing Immunity: A Personalized, Multi-Target Approach to Cancer At the UK National Health Service Annual Oncology Conference

ConferenceDCVaxNeutral
AI Analysis

Summary

Northwest Biotherapeutics announced that its Chief Technical Officer, Dr. Marnix Bosch, will deliver a keynote presentation on personalized, multi-target immunotherapy approaches to cancer at the UK National Health Service Annual Oncology Conference.

Importance:2/10
Sentiment:
0.00
immunotherapypersonalized medicineoncologyconference presentationDCVax
Related Companies

Read the original article

Published by PR Newswire Biotech on October 6, 2026 7:00 AM

Read Original